Skip to main content

7 February 2026

Last updated: Friday 6 February 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Genmab looks ahead to next phase of growth

Sunday 11 November 2018

Interviewee/Contributor

Jan van de Winkel

Organisation

Genmab A/S

Why industry is investing in bispecific molecules

Wednesday 15 June 2016

Interviewee/Contributor

Jan van de Winkel

Organisation

Genmab A/S

Organisations

Exscientia Ltd
ISA Pharmaceuticals BV
Alnylam Pharmaceuticals Inc
Verona Pharma Plc
Complement Therapeutics Ltd
CNS Pharmaceuticals Inc
Ariceum Therapeutics GmbH
Cytograft Tissue Engineering Inc
Paul Capital Healthcare
Lawford Davies Denoon

Interviewees and Contributers

Simon Kerry
Shayesteh Fürst-Ladani
Graham Burnett-Hall
Tim Sturgeon
Thomas G Evans
Jean-Claude Muller
Nigel Parker
Sean Smith, Jeffrey Abbey and Steve Coats
Chris Maggos

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

German biotech DISCO Pharmaceuticals appoints CEO

Monday 19 January 2026

argenx in CEO transition

Monday 19 January 2026

PureTech Health appoints CEO

Monday 19 January 2026

New CEO at Tacalyx

Monday 19 January 2026

Tubulis appoints oncology expert as CMO

Monday 19 January 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form